Category survey

Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Investigating the Role of the Histone Demethylase LSD1/KDMI in Neurodegeneration Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

TDP-43, RNA Metabolism, and ALS/FTD Pathology Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

eIF2alpha Phosphorylation in Synaptic Plasticity, Memory, and Brain Disorders Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The Cdk5/35 Kinase Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Interplay between cArt, HIV, and amyloid at the blood-brain barrier. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Understanding the roles of slow and fast gamma rhythms in memory processing Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Deconstructing the pathogenic effect of APP in memory circuits Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The role of acetylation in regulating pathophysiology of tau Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

1/2 Phenotype Predictors of Cognitive Outcomes in Geriatric Depression Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mechanism and Synergy of gamma-Secretase Modulators Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Hexanucleotide repeat translation in ALS and Frontotemporal Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Regulation of Protein Trafficking in Neurodegeneration Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Role of C9orf72 in Neurodegeneration Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Early Detection and Prevention of Mild Cognitive Impairment due to Cerebrovascular Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The Role of Copper in Cerebral Amyloid Angiopathy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Functional Analysis of Sleep Promoting Neurons in Health and Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Function of TMEM106B in neurodegeneration Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Functional Amyloid in Melansome Biogenesis Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Role of Cholinergic-Glutamatergic Co-transmission in Forebrain Circuits Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Investigating disease Mechanisms in C9orf72-linked ALS/FTD Investments > €500k United States of America Alzheimer’s disease & other dementias|Huntington’s disease|Motor neurone diseases 2016    

Failure of metabolite clearance in a model of multi-lacunar infarcts Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Gene discovery in PSP by transcriptome, neuropathology and sequence analysis Investments > €500k United States of America Neurodegenerative disease in general 2016    

Animal Models for Studying Human Frontotemporal Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The role of apoE and APOE genotype in amyloid-beta clearance after TBI Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

2/2 Phenotype Predictors of Cognitive Outcomes in Geriatric Depression Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

OVEREXPRESSION OF APP AND CEREBROVASCULAR REGULATION Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Algorithms for Glyco-Proteoform Detection Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

ACAT inhibitors regulate palmitoylated APP and Abeta production Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

4D Software Tools for Longitudinal Prediction of Brain Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Lewy body neuropathologies and SNCA gene: variants expression and splicing Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Environment and cognitive decline in older Hispanics Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mechanisms Underlying Tau45-230-Induced Neuronal Degeneration Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

A molecular anatomic imaging analysis of tau in progressive supranuclear palsy Investments > €500k United States of America Neurodegenerative disease in general 2016    

FUNCTIONAL ANALYSIS OF SLEEP HOMEOSTASIS IN DROSOPHILA Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Novel Multiplexing Proteomics to Study the Periphery in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Cerebral Small Vessels in Motor and Cognitive Decline Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Regulation of Mitochondrial Quality Through Mitophagy in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The Genetic Regulation and Disease Function of the Frontotemporal Dementia Protei Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Impact of Ambient Ultrafine Particle Exposures on Alzheimers Disease Progression Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Molecular genetic studies of progranulin regulators in FTLD and ALS Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The role of Clusterin in cerebral amyloid angiopathy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Synaptic Depression: Focus on Cdk5 Signaling Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Molecular Imaging of Biomaterials – Single Cells Investments > €500k United States of America Alzheimer’s disease & other dementias 2016